On the contrary, a matched control study reported that cancer patients with thrombosis had a higher prevalence of aPL positivity (8.0%), compared to cancer patients without thrombosis (1.4%) and healthy controls (0.4%) [17]. The gene discussed is FASLG; the disease is cancer.